Why Eczema Skin Is Vulnerable to Staphylococcus aureus Infection?
- Marcelline Goyen
- Mar 20
- 8 min read
Updated: Jun 10
A Deep Dive into the Eczema Infection
By Marcelline Goyen, BSc
Registered Dermal Therapist, Skin-Gut Axis Specialist & Author
Published on: March 20, 2026
Table of Contents
Introduction
Atopic dermatitis, commonly known as eczema, is a chronic, multi-factorial inflammatory skin disorder that compromises the daily lives of millions globally. While clinical treatments traditionally focus on localized immune suppression, a major complication in dermatological practice is the high susceptibility of eczematous tissue to secondary bacterial infections. Chief among these pathogenic opportunists is Staphylococcus aureus, a bacterium that seamlessly colonizes and dominates the compromised epidermal terrain of eczema patients. Understanding the intricate mechanics of the eczema infection microbiome—the complex, invisible ecosystem of microorganisms residing on and within the epidermal layers—is paramount to identifying why these structural infections manifest and how they can be systematically managed or prevented through advanced, microbiome-targeted interventions.
What Is Eczema and How Does It Affect the Epidermal Barrier?
Atopic dermatitis is characterized by dry, pruritic, and deeply inflamed erythematous plaques. While its etiology involves complex genetic predispositions, such as loss-of-function mutations in the filaggrin gene (FLG), the primary clinical hallmark of eczema is a profoundly compromised stratum corneum. In a healthy physiological state, the skin barrier functions as an impermeable shield, locking in moisture via lipid matrices and locking out external environmental stressors.
In eczematous skin, this structural integrity is severely degraded. The compromised barrier exhibits an elevated rate of transepidermal water loss (TEWL), which induces severe cellular xerosis and creates microscopic fissures across the epidermis. This structural breakdown allows external irritants, airborne allergens, and opportunistic pathogens to penetrate the deeper epidermal layers with ease. Once inside, these foreign elements trigger robust, cell-mediated immune responses (Th2-skewed cascades) that perpetuate chronic inflammation and establish a highly favorable, vulnerable environment where harmful bacteria like Staphylococcus aureus can rapidly adhere, colonize, and infect.
Understanding the Skin Microbiome in Atopic Dermatitis
The healthy human skin surface is home to a highly diverse and dynamic microbiome composed of thousands of symbiotic bacteria, fungi, and viruses. In a homeostatic state, this resident microbial community acts as an active immunological shield. These beneficial microorganisms protect the host from infection by physically outcompeting foreign pathogens for cellular space and vital nutritional resources, while simultaneously synthesizing targeted antimicrobial peptides (AMPs) that actively suppress pathogenic colonization.
In patients navigating eczema, this delicate equilibrium is profoundly disrupted, culminating in severe cutaneous dysbiosis. Molecular analyses reveal that eczematous skin is characterized by a drastic reduction in overall microbial diversity and a simultaneous, disproportionate overgrowth of Staphylococcus aureus.
Skin microbiome, Eczema and skin acidity (pH)
A primary driver of this dysbiosis lies in the alteration of the skin's natural acid mantle. While healthy skin maintains an acidic pH (typically between 4.5 and 5.5) to inhibit pathogenic growth and optimize barrier enzymes, eczematous skin exhibits a pathologically elevated, more alkaline pH. This shift toward alkalinity deactivates the skin's natural defense proteins and creates an ideal biochemical environment for Staphylococcus aureus to flourish, while decimating protective resident strains such as Staphylococcus epidermidis.
Crucial Dynamics of the Cutaneous Dysbiosis:
Severe Loss of Microbial Diversity: The loss of protective, resident microbial species diminishes the skin's baseline defense mechanisms, lowering the threshold required for pathogenic colonization.
Pathogenic Dominance of S. aureus: As Staphylococcus aureus multiplies, it produces highly destructive exfoliative toxins and enzymes that physically degrade cellular adhesion molecules within the stratum corneum.
The Dual Nature of Staphylococcus epidermidis: While Staphylococcus epidermidis is fundamentally a beneficial resident bacterium that produces protective AMPs, specific environmental pressures and antibiotic exposure can cause certain strains to mutate into opportunistic pathogens, such as multi-drug resistant Methicillin-Resistant Staphylococcus epidermidis (MRSE).
Microbial Fluctuation During Flares: The cutaneous microbiome is highly dynamic; clinical data demonstrates that S. aureus populations peak exponentially during acute eczema exacerbations, directly driving the severity of the inflammatory flare.
The Pathological Role of Staphylococcus Aureus in Eczema Infections
Staphylococcus aureus is a ubiquitous bacterium frequently found on the skin or within the nasal passages of a small percentage of the healthy population without causing clinical symptoms. However, within the context of atopic dermatitis, this bacterium transitions into a highly destructive pathogen due to the inherent vulnerabilities of the compromised epidermal barrier.
Dermatological statistics show that up to 90% of eczema patients suffer from chronic S. aureus colonization, compared to less than 30% of healthy individuals. Once established, S. aureus synthesizes and secretes potent toxins that act as superantigens. These superantigens bypass conventional immune regulatory pathways, overstimulating T-cells and unleashing a massive storm of pro-inflammatory cytokines that exponentially worsen localized swelling, itching, and tissue damage. Furthermore, the persistent presence of this pathogen actively impairs the skin's natural cellular regeneration cycles, prolonging the duration of acute flares. This clinical complexity is further exacerbated by the rise of antibiotic-resistant strains, such as Methicillin-Resistant Staphylococcus aureus (MRSA), which severely complicate standard dermatological treatment protocols.
Microbial Interactions: S. aureus versus S. epidermidis
Under healthy conditions, S. aureus and S. epidermidis function as competitive peers within the skin's ecosystem, actively keeping one another's populations in check through the secretion of localized antimicrobial peptides. They are, in essence, structural colleagues in the skin's defense network. However, when the skin's pH rises and structural lipids deplete, this natural checks-and-balances system collapses. The overproliferation of one species floods the microenvironment with aggressive AMPs that suppress the other, shifting the entire topography from a state of healthy symbiosis to aggressive, infection-prone dysbiosis.
How the Gut Microbiome Influences Cutaneous Immunity
The health of the cutaneous surface is intimately bound to the internal biology of the gastrointestinal tract via the bidirectional pathways of the gut-skin axis. The trillions of microbes colonizing the digestive system serve as the primary educators of the systemic immune system, directly impacting inflammatory expressions on the skin.
A diverse and well-balanced gut microbiome synthesizes crucial metabolic byproducts, such as short-chain fatty acids (SCFAs), which circulate systemically to reinforce the structural integrity of both the intestinal mucosa and distant epithelial tissues. Conversely, gastrointestinal dysbiosis and increased intestinal permeability allow systemic endotoxins to escape into the bloodstream, triggering low-grade, chronic systemic inflammation. This internal immune activation increases the skin's susceptibility to localized allergic responses and significantly impairs its capacity to mount an effective defense against external bacterial pathogens like S. aureus.
Clinical Strategies to Support a Resilient Skin Microbiome
Successfully managing Staphylococcus aureus colonization and mitigating secondary eczema infections requires a comprehensive therapeutic approach that addresses both topical and systemic factors:
Advanced Topical Care Practices:
Implement Physiological, Low-pH Cleansing: Transition exclusively to mild, non-ionic, fragrance-free syndet cleansers that preserve the skin's delicate acid mantle and protect beneficial resident microbes.
Maintain Consistent Lipid-Identical Moisturization: Apply advanced barrier-repair creams rich in ceramides, cholesterol, and free fatty acids to seal physical fissures, reduce TEWL, and restore a hospitable environment for a diverse microbiome.
Practice Strict Antibiotic Stewardship: Avoid the indiscriminate use of topical or oral broad-spectrum antibiotics for non-infected flares, as overuse decimates beneficial bacteria and accelerates the development of resistant strains like MRSA.
Explore Biomimetic Topical Therapies: Consider emerging skincare technologies utilizing targeted postbiotic lysates or paraprobiotics designed to selectively inhibit pathogens while nourishing protective skin flora.
Gastrointestinal and Metabolic Interventions:
Collaborate with a Specialized Gut Therapist: For severe or chronic cases, seek the expertise of a qualified professional to execute advanced diagnostic stool testing and develop tailored, internal protocols to rectify deep-seated gastrointestinal dysbiosis.
Integrate Targeted Oral Prebiotics and Probiotics: Under professional guidance, incorporate scientifically validated prebiotic fibers (such as inulin or psyllium) alongside specific clinical probiotic strains known to down-regulate systemic inflammation via the gut-skin axis.
Adopt a Diverse, Nutrient-Dense Diet: Consume a whole-food diet rich in dietary fibers, diverse antioxidants, and natural fermented foods (such as kefir or unsweetened sauerkraut) to systematically enhance internal microbial diversity and bolster systemic immunological resilience.
For additional insights and practical tips, don’t miss my related article on this topic Underlying Eczema Causes: Examining 5 Hidden Triggers Beyond Surface Dryness.
Frequently Asked Questions (FAQ)
What primary factors trigger secondary bacterial infections in eczema?
Secondary infections are primarily triggered by the combination of a structurally fractured skin barrier, an elevated (more alkaline) skin pH, and a profound loss of microbial diversity. This allows opportunistic pathogens like Staphylococcus aureus to colonize the epidermis without natural competition.
Why does Staphylococcus aureus worsen the severity of eczema flares?
S. aureus secretes highly destructive toxins known as superantigens. These compounds hyper-activate the host's immune system, triggering an excessive release of pro-inflammatory cytokines that accelerate tissue damage, intense itching, and prolonged inflammation.
Can optimizing gastrointestinal health reduce the frequency of skin infections?
Yes. Modulating the gut microbiome stabilizes systemic immunity, reduces circulating inflammatory markers, and enhances the skin's natural capacity to synthesize antimicrobial peptides, thereby reducing susceptibility to cutaneous infections.
Is the use of probiotics clinically proven to alleviate atopic dermatitis?
Clinical studies show that specific, strain-verified probiotic supplements can effectively modulate immune responses and reduce eczema severity scores. However, because therapeutic outcomes are highly strain-specific, generic supplementation may yield inconsistent results.
How can patients safely manage S. aureus colonization without inducing antibiotic resistance?
Patients should focus on non-pharmacological strategies that restore the skin's natural defenses, such as utilizing low-pH skincare to re-acidify the acid mantle, maintaining barrier integrity through ceramide-dominant moisturizers, and supporting internal gut health.
Summary and Next Steps
The complexities of the eczema infection microbiome illustrate that recurrent Staphylococcus aureus infections are not random occurrences, but rather the logical outcome of a compromised skin barrier, altered cutaneous pH, and internal gastrointestinal dysbiosis. Successfully breaking this cycle requires moving beyond temporary topical suppression toward a sophisticated routine that honors the intricate pathways of the gut-skin axis.
By implementing gentle, low-pH skincare, adopting a nutrient-dense, prebiotic-rich diet, and proactively managing lifestyle stressors, you can systematically restore microbial diversity and reinforce your skin's natural defenses. If you or your clients are navigating severe, recurrent infections, consider collaborating with an experienced clinician or specialized gut therapist to design a highly personalized, biology-backed protocol for sustainable epidermal rehabilitation.
To discover more evidence-based research and advanced clinical insights into the relationship between intestinal wellness and dermatological health, explore our specialized publications at www.skin-gut-axis.com.
References & Further Reading
Bowe, W. P., & Logan, A. C. (2011). Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future? Gut Pathogens, 3(1), 1. PubMed Central Link
Goyen MTM. (2019) The Skin-Gut Connection (Dutch) Volume I
Goyen MTM. (2023) The amazing world of the Skin-Gut Axis, including the role of the Microbiome Volume II
Guan, W., et al. (2025). Skin Diseases and Barrier Dysfunction Linked to Air Pollution. Annals of Allergy, Asthma & Immunology. AJMC Medical Journal Review (2025)
Proksch, E., Brandner, J. M., & Jensen, J. M. (2008). The skin barrier in healthy and diseased state. Journal of Dermatological Science, 50(1), 1-12. ScienceDirect Link
⚖️ Medical Disclaimer: The information provided on this website, including articles, textbook references, and educational materials, is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Marcelline Goyen, BSc | Registered Dermal Therapist & Author (The Netherlands)
Founder of www.skin-gut-axis.com
About Marcelline Goyen, BSc Marcelline Goyen, BSc is a Registered Dermal Therapist, professional educator, and author specializing in the complex mechanics of the skin-gut axis. With over two decades of clinical experience, she is recognized as a pioneer and authority in understanding the skin-gut-brain connection. To make her specialized knowledge more widely accessible, her expertise has culminated in the publication of two books, which have since become fundamental literature for holistic skin rehabilitation. Alongside her writing, she shares her insights globally through masterclasses and webinars. Discover more about her books and clinical vision at www.skin-gut-axis.com.
Comments